FDA Roundup: November 15, 2024
FDA Roundup: November 15, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-15-2024
Endoscopic Vessel Harvesting System Recall: Getinge and Maquet Cardiovascular Remove VasoView HemoPro 1 and 1.5 Endoscopic Vessel
FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-aromatic-l-amino-acid-decarboxylase-deficiency
FDA Roundup: November 8, 2024
FDA Roundup: November 8, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-8-2024
FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review
FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review
http://www.fda.gov/news-events/press-announcements/fda-proposes-ending-use-oral-phenylephrine-otc-monograph-nasal-decongestant-active-ingredient-after
VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra and PeakMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac
FDA Roundup: November 5, 2024
FDA Roundup: November 5, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-5-2024
Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac
FDA Roundup: November 1, 2024
FDA Roundup: November 1, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-1-2024